PsyMuKB

PPI network (data source: BioGrid)

A gene is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the mean normalized expression(base 2 log of (TPM+1)) +1 in all brain tissue from GTEx v7 or BrainSpan data.

A protein is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the normalized expression (base 10 log of iBAQ intensity) ≥0.5 in at least one brain tissue from ProteomicsDB data. Otherwise, a gene or protein is determined as either with below-cutoff expressions or no available data.

	The queried gene/protein
	The interacting partner is expressed at mRNA-level
	The interacting partner is expressed at protein-level
	The interacting partner is expressed at both mRNA and protein level
	The interacting partner is with either below-cutoff expressions or no expression data at both mRNA and protein level
	The interacting partner is hit by coding DNMs
	Physical interaction between queried gene/protein and its partner
	Physical interaction between two interacting partners

Symbol A	GeneA coding DNM count	Symbol B	GeneB coding DNM count	Interaction detection method	Publication	Evidence
NSD3	6	TERT	7	fluorescent resonance energy transfe	Ivanov AA (2017)	1
ESR1	0	8339	0	pull down	Nalvarte I (2010)	1
TGFB1	2	NSD3	6	two hybrid	Arroyo R (2015)	1
AKT1	1	TERT	7	affinity chromatography technology, affinity chromatography technology, fluorescent resonance energy transfe	Kawauchi K (2005), Kim MO (2008), Ivanov AA (2017)	3
NSD3	6	LSM3	2	affinity chromatography technology	Hein MY (2015)	1
SOX3	0	CDKN2A	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
HIST1H3A	3	H2AFY	1	imaging technique, affinity chromatography technology, affinity chromatography technology	Soldi M (2013), Sarma K (2014), Huttlin EL (2017)	3
NSD3	6	HIST3H3	0	pull down, pull down, x-ray crystallography	He C (2013), He C (2013), He C (2013)	3
UBE2I	0	HIST1H4A	0	pull down, enzymatic study	Shiio Y (2003), Shiio Y (2003)	2
HIST1H3A	3	BRD2	2	bioid	Lambert JP (2015)	1
TEAD2	2	H2AFY	1	affinity chromatography technology	Li X (2015)	1
SOX3	0	TERT	7	fluorescent resonance energy transfe	Ivanov AA (2017)	1
HIST1H3A	3	PPM1D	11	affinity chromatography technology, pull down	Zhang H (2013), Zhang H (2013)	2
NSD3	6	NFIC	5	fluorescent resonance energy transfe	Ivanov AA (2017)	1
MYC	2	TEAD2	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
FGFR4	6	NSD3	6	two hybrid	Arroyo R (2015)	1
CBLC	1	TERT	7	fluorescent resonance energy transfe	Ivanov AA (2017)	1
SMARCA4	19	SMARCC1	5	biochemical, biochemical, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, biochemical, biochemical	Sif S (2001), Wang W (1996), Otsuki T (2001), Zhao K (1998), Kaeser MD (2008), Kaeser MD (2008), Kaeser MD (2008), Kaeser MD (2008), Inayoshi Y (2006), Inayoshi Y (2006), Pal S (2003), Pal S (2003), Bultman SJ (2005), Nagl NG (2005), Mahajan MC (2005), Trotter KW (2008), Dallas PB (1998), Tando T (2010), Tando T (2010), Bartlett C (2011), Bartlett C (2011), Oh J (2008), Oh J (2008), Havugimana PC (2012), Wan C (2015)	25
GLIS2	2	SOX3	0	fluorescent resonance energy transfe	Ivanov AA (2017)	1
RAD51	3	UBE2I	0	two hybrid, two hybrid	Kovalenko OV (1996), Shen Z (1996)	2
NSD3	6	BOD1L1	11	affinity chromatography technology	Shen C (2015)	1
ZNF557	3	NSD3	6	two hybrid	Weimann M (2013)	1
AKT1	1	ESR1	0	enzymatic study	Campbell RA (2001)	1
BRD4	8	NSD3	6	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, pull down, affinity chromatography technology	Rahman S (2011), Rahman S (2011), Rahman S (2011), Rahman S (2011), French CA (2014), French CA (2014), Shen C (2015), Shen C (2015), Shen C (2015), Shen C (2015)	10
FGFR4	6	AKT1	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
TERT	7	TEAD2	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
CBX5	3	BCL7A	3	affinity chromatography technology	Nozawa RS (2010)	1
HIST1H4A	0	CBX3	1	pull down	Shiio Y (2003)	1
HIST1H3A	3	BPTF	8	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology	Wysocka J (2006), Wysocka J (2006), Wysocka J (2006)	3
8339	0	YEATS4	0	bioid	Lambert JP (2015)	1
HIST1H1A	0	NSD3	6	two hybrid	Weimann M (2013)	1
CBX3	1	NSD3	6	two hybrid	Bandyopadhyay S (2010)	1
CDKN2A	1	MYC	2	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, fluorescent resonance energy transfe	Herkert B (2010), Amente S (2007), Zhang Q (2013), Ivanov AA (2017)	4
CHD8	44	BRD4	8	affinity chromatography technology, affinity chromatography technology	Shen C (2015), Shen C (2015)	2
HIST1H3A	3	DAXX	5	affinity chromatography technology	Huttlin EL (2017)	1
NFIC	5	MYC	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
NSD3	6	H2AFY	1	affinity chromatography technology	Rahman S (2011)	1
NSD3	6	BPTF	8	affinity chromatography technology	Shen C (2015)	1
RB1CC1	9	NSD3	6	two hybrid	Arroyo R (2015)	1
TERT	7	FGFR4	6	fluorescent resonance energy transfe	Ivanov AA (2017)	1
SMARCA2	17	BCL7C	0	biochemical, affinity chromatography technology	Wan C (2015), Huttlin EL (2017)	2
8339	0	NSD3	6	bioid	Lambert JP (2015)	1
UBE2I	0	CDKN2A	1	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, imaging technique	Rizos H (2005), Wang S (2015), Ivanschitz L (2015), Ivanschitz L (2015), Ivanschitz L (2015)	5
CBLC	1	AKT1	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
CDKN2A	1	SMARCA4	19	two hybrid, affinity chromatography technology	Becker TM (2009), Becker TM (2009)	2
SMARCA2	17	BCL7A	3	affinity chromatography technology, biochemical, affinity chromatography technology	Tando T (2010), Wan C (2015), Huttlin EL (2017)	3
HIST3H3	0	H2AFY	1	affinity chromatography technology	Chen H (2014)	1
MYC	2	CCNT1	3	affinity chromatography technology, pull down, affinity chromatography technology, pull down, affinity chromatography technology	Kanazawa S (2003), Kanazawa S (2003), Bres V (2009), Eberhardy SR (2001), Gargano B (2007)	5
NSD3	6	BCL7A	3	affinity chromatography technology	Rahman S (2011)	1
HIST1H4A	0	DAXX	5	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology	Saade E (2009), Saade E (2009), Hollenbach AD (2002), Huttlin EL (2017)	4
NSD3	6	GLIS2	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
SMARCA4	19	HIST1H3A	3	pull down, pull down, pull down	Lavigne M (2009), Lavigne M (2009), Kouskouti A (2005)	3
HIST1H3A	3	BRD4	8	affinity chromatography technology, fluorescent resonance energy transfe, affinity chromatography technology	Zippo A (2009), Zippo A (2009), Zippo A (2009)	3
GLYR1	3	KDM1B	4	affinity chromatography technology, affinity chromatography technology	Huttlin EL (2015), Huttlin EL (2017)	2
HIST1H3A	3	CBX3	1	affinity chromatography technology, pull down, pull down, x-ray crystallography, unspecified method	Kutney SN (2004), Lavigne M (2009), Lavigne M (2009), Allen HF (2014), Allen HF (2014)	5
NSD3	6	SMARCA4	19	affinity chromatography technology	Rahman S (2011)	1
CCNT1	3	ESR1	0	affinity chromatography technology, affinity chromatography technology, pull down, imaging technique	Wittmann BM (2005), Wittmann BM (2005), Wittmann BM (2005), Wittmann BM (2005)	4
KDM1B	4	NSD3	6	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology	Fang R (2010), Fang R (2010), Hein MY (2015), Hein MY (2015)	4
HIST1H3A	3	GLYR1	3	pull down	Sankaran SM (2016)	1
ESR1	0	MYC	2	affinity chromatography technology	Cheng AS (2006)	1
CDKN2A	1	TEAD2	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
NSD3	6	SOX3	0	fluorescent resonance energy transfe	Ivanov AA (2017)	1
ATM	9	DAXX	5	enzymatic study	Tang J (2013)	1
RAD51	3	NSD3	6	two hybrid, affinity chromatography technology, affinity chromatography technology	Arroyo R (2015), Arroyo R (2015), Arroyo R (2015)	3
GLIS2	2	AKT1	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
BCAR3	5	NSD3	6	two hybrid	Arroyo R (2015)	1
HOXC4	1	NSD3	6	affinity chromatography technology, two hybrid	Weimann M (2013), Weimann M (2013)	2
MYC	2	UBE2I	0	genetic interference	Toyoshima M (2012)	1
GLIS2	2	TERT	7	fluorescent resonance energy transfe	Ivanov AA (2017)	1
GLIS2	2	CDKN2A	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
NFIC	5	GLIS2	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
BRD2	2	NSD3	6	affinity chromatography technology	Hein MY (2015)	1
SS18L1	2	SMARCA4	19	affinity chromatography technology, pull down	Qiu Z (2008), Qiu Z (2008)	2
SPAG8	0	NSD3	6	two hybrid	Weimann M (2013)	1
CBX5	3	HIST3H3	0	affinity chromatography technology, unspecified method, x-ray crystallography, pull down, unspecified method, unspecified method, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, unspecified method, pull down	Quivy JP (2004), Kaustov L (2011), Kaustov L (2011), Bartke T (2010), Li X (2012), Li X (2012), Vermeulen M (2007), Kubota S (2013), Vermeulen M (2010), Vermeulen M (2010), Lacroix M (2008)	11
NSD3	6	BRD9	2	affinity chromatography technology	Rahman S (2011)	1
YEATS4	0	MLLT6	2	affinity chromatography technology	Hein MY (2015)	1
UBE2I	0	SOX4	5	two hybrid, affinity chromatography technology, affinity chromatography technology	Pan X (2006), Pan X (2006), Pan X (2006)	3
NSD3	6	BCL7C	0	affinity chromatography technology	Rahman S (2011)	1
STAC3	1	NSD3	6	two hybrid	Weimann M (2013)	1
PPM1D	11	NSD3	6	two hybrid	Arroyo R (2015)	1
CDKN2A	1	AKT1	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
NSD3	6	MYC	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
YEATS4	0	NSD3	6	affinity chromatography technology	Hein MY (2015)	1
BCL7A	3	BRD9	2	affinity chromatography technology	Huttlin EL (2017)	1
NSD3	6	SS18L1	2	affinity chromatography technology	Rahman S (2011)	1
GLIS2	2	MYC	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
NSD3	6	CBLC	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
NFIC	5	CBLC	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
UBE2I	0	TCF3	7	pull down, two hybrid	Huggins GS (1999), Huggins GS (1999)	2
MYC	2	ETV3	1	affinity chromatography technology	Agrawal P (2010)	1
RAD51	3	ESR1	0	affinity chromatography technology, affinity chromatography technology	Jung YS (2014), Jung YS (2014)	2
CBX5	3	NSD3	6	two hybrid, two hybrid	Rolland T (2014), Yu H (2011)	2
MLLT6	2	NSD3	6	two hybrid	Rolland T (2014)	1
HIST1H3A	3	SMARCA2	17	pull down, pull down	Lavigne M (2009), Lavigne M (2009)	2
HIST3H3	0	GLYR1	3	unspecified method	Vermeulen M (2010)	1
BRD4	8	BRD2	2	affinity chromatography technology	Rahman S (2011)	1
BRD4	8	BRD9	2	affinity chromatography technology	Rahman S (2011)	1
YEATS4	0	HIST3H3	0	affinity chromatography technology	Wang Y (2018)	1
NSD3	6	HIST1H4A	0	enzymatic study	Morishita M (2014)	1
TCF3	7	DAXX	5	pull down	Gupta A (2009)	1
BCL7C	0	BRD9	2	affinity chromatography technology	Huttlin EL (2017)	1
SMARCA2	17	SMARCC1	5	biochemical, biochemical, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, biochemical, biochemical	Sif S (2001), Wang W (1996), Hu K (2006), Hu K (2006), Inayoshi Y (2006), Inayoshi Y (2006), Pal S (2003), Pal S (2003), Nagl NG (2005), Nakamura T (2002), Tando T (2010), Tando T (2010), Havugimana PC (2012), Wan C (2015)	14
BRD4	8	CCNT1	3	affinity chromatography technology, affinity chromatography technology, pull down, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, pull down, affinity chromatography technology, affinity chromatography technology	Jang MK (2005), Jang MK (2005), Jang MK (2005), Yang Z (2008), Rahman S (2011), Bisgrove DA (2007), Bisgrove DA (2007), Yang Z (2005), Lu H (2014)	9
HIST1H3A	3	HIST1H4A	0	affinity chromatography technology, pull down, affinity chromatography technology, imaging technique, affinity chromatography technology, pull down	Tagami H (2004), Shiio Y (2003), Zippo A (2009), Soldi M (2013), Klement K (2014), Sato K (2012)	6
CDKN2A	1	DAXX	5	pull down, affinity chromatography technology, affinity chromatography technology	Ivanchuk SM (2008), Ivanchuk SM (2008), Ivanchuk SM (2008)	3
PAX2	2	NSD3	6	two hybrid	Arroyo R (2015)	1
CHEK2	2	BRD4	8	genetic interference	Srivas R (2016)	1
AKT1	1	SMARCC1	5	affinity chromatography technology, enzymatic study, pull down	Foster KS (2006), Foster KS (2006), Foster KS (2006)	3
CDKN2A	1	TERT	7	fluorescent resonance energy transfe	Ivanov AA (2017)	1
MYC	2	SMARCA2	17	pull down	Pal S (2003)	1
KDM1B	4	CCNT1	3	affinity chromatography technology, affinity chromatography technology	Fang R (2010), Fang R (2010)	2
CHEK2	2	PPM1D	11	pull down, pull down, enzymatic study, affinity chromatography technology	Fujimoto H (2006), Fujimoto H (2006), Fujimoto H (2006), Fujimoto H (2006)	4
SOX4	5	MYC	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
MYC	2	FGFR4	6	fluorescent resonance energy transfe	Ivanov AA (2017)	1
MYC	2	SMARCC1	5	pull down, affinity chromatography technology	Pal S (2003), Koch HB (2007)	2
NSD3	6	NSD3	6	fluorescent resonance energy transfe	Ivanov AA (2017)	1
BCL7A	3	SMARCC1	5	biochemical, affinity chromatography technology	Wan C (2015), Huttlin EL (2017)	2
CDKN2A	1	FGFR4	6	fluorescent resonance energy transfe	Ivanov AA (2017)	1
HIST3H3	0	CBX3	1	unspecified method, x-ray crystallography, unspecified method	Kaustov L (2011), Kaustov L (2011), Vermeulen M (2010)	3
CBX3	1	H2AFY	1	biochemical	Havugimana PC (2012)	1
SOX4	5	AKT1	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
MYC	2	SMARCA4	19	affinity chromatography technology, affinity chromatography technology, pull down, fluorescent resonance energy transfe	Ewing RM (2007), Park J (2002), Pal S (2003), Ivanov AA (2017)	4
CBX5	3	H2AFY	1	biochemical	Havugimana PC (2012)	1
DAXX	5	CBX5	3	affinity chromatography technology	Hein MY (2015)	1
ESR1	0	UBE2I	0	two hybrid, enzymatic study	Kobayashi S (2004), Sentis S (2005)	2
SOX4	5	TERT	7	fluorescent resonance energy transfe	Ivanov AA (2017)	1
BRD4	8	SMARCA4	19	affinity chromatography technology	Rahman S (2011)	1
SMARCA4	19	BCL7A	3	affinity chromatography technology, biochemical, affinity chromatography technology	Tando T (2010), Wan C (2015), Huttlin EL (2017)	3
BCL7C	0	SMARCA4	19	affinity chromatography technology, biochemical, affinity chromatography technology	Kaeser MD (2008), Wan C (2015), Huttlin EL (2017)	3
DAXX	5	TERT	7	affinity chromatography technology	Tang M (2015)	1
NSD3	6	CRNN	3	affinity chromatography technology	Rahman S (2011)	1
UBE2I	0	CBLC	1	two hybrid	Markson G (2009)	1
DAXX	5	HIST3H3	0	affinity chromatography technology	Tang M (2015)	1
ESR1	0	GLYR1	3	affinity chromatography technology	Tarallo R (2011)	1
NFIC	5	SOX3	0	fluorescent resonance energy transfe	Ivanov AA (2017)	1
ESR1	0	NSD3	6	two hybrid	Arroyo R (2015)	1
CBX3	1	CBX5	3	affinity chromatography technology, affinity chromatography technology, pull down, pull down, imaging technique, affinity chromatography technology, affinity chromatography technology, biochemical, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology	Nielsen AL (2001), Nielsen AL (2001), Nielsen AL (2001), Nielsen AL (2001), Mateos-Langerak J (2007), Quivy JP (2004), Quivy JP (2004), Quivy JP (2004), Kiyomitsu T (2010), Rosnoblet C (2011), Nozawa RS (2010), Vermeulen M (2010), Vermeulen M (2010), Hauri S (2016), Hauri S (2016)	15
ATM	9	NSD3	6	two hybrid, affinity chromatography technology	Arroyo R (2015), Arroyo R (2015)	2
SOX4	5	SMARCA4	19	fluorescent resonance energy transfe	Ivanov AA (2017)	1
CDC14B	1	GLYR1	3	bioid	St-Denis N (2016)	1
DAXX	5	NSD3	6	affinity chromatography technology, two hybrid	Weimann M (2013), Weimann M (2013)	2
GLIS2	2	TEAD2	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
UBE2I	0	DAXX	5	two hybrid, enzymatic study, affinity chromatography technology, pull down, enzymatic study, enzymatic study, enzymatic study, two hybrid	Ryu SW (2000), Knipscheer P (2008), Hsieh YL (2013), Hsieh YL (2013), Hsieh YL (2013), Chang CC (2011), Lin DY (2006), Lin DY (2006)	8
DOCK7	3	NSD3	6	two hybrid	Weimann M (2013)	1
NFIC	5	TEAD2	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
SOX4	5	CDKN2A	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
SLU7	2	NSD3	6	affinity chromatography technology, two hybrid	Weimann M (2013), Weimann M (2013)	2
GLIS2	2	FGFR4	6	fluorescent resonance energy transfe	Ivanov AA (2017)	1
CDC14B	1	BRD2	2	bioid	St-Denis N (2016)	1
NSD3	6	SMARCA2	17	affinity chromatography technology	Rahman S (2011)	1
SMARCA4	19	SMARCA2	17	biochemical, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, biochemical	Reyes JC (1997), Pal S (2003), Ito T (2008), Ito T (2008), Havugimana PC (2012)	5
BCL7A	3	BCL7C	0	affinity chromatography technology	Huttlin EL (2017)	1
NSD3	6	TEAD2	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
8339	0	BRD2	2	bioid	Lambert JP (2015)	1
MYC	2	BRD4	8	genetic interference	Toyoshima M (2012)	1
SEPT6	0	NSD3	6	two hybrid	Weimann M (2013)	1
GLYR1	3	NSD3	6	two hybrid	Weimann M (2013)	1
NSD3	6	TCF3	7	fluorescent resonance energy transfe	Ivanov AA (2017)	1
SMARCC1	5	SS18L1	2	biochemical	Wan C (2015)	1
8339	0	KDM1B	4	bioid	Lambert JP (2015)	1
SOX3	0	MYC	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
UBE2I	0	NSD3	6	two hybrid	Weimann M (2013)	1
NSD3	6	CHD8	44	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology	Shen C (2015), Shen C (2015), Shen C (2015)	3
BRD2	2	HIST1H4A	0	pull down, affinity chromatography technology, affinity chromatography technology, fluorescent resonance energy transfe, unspecified method, fluorescent resonance energy transfe	Nakamura Y (2007), Kanno T (2004), Kanno T (2004), Kanno T (2004), Kanno T (2004), Zippo A (2009)	6
CBLC	1	FGFR4	6	fluorescent resonance energy transfe	Ivanov AA (2017)	1
CCNT1	3	NSD3	6	affinity chromatography technology	Fang R (2010)	1
CDC14B	1	NSD3	6	bioid	St-Denis N (2016)	1
BRD4	8	HIST1H4A	0	fluorescent resonance energy transfe, affinity chromatography technology	Zippo A (2009), Zippo A (2009)	2
NSD3	6	HIST1H3A	3	enzymatic study, pull down	Morishita M (2014), Sankaran SM (2016)	2
GLIS2	2	CBLC	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
MYC	2	TERT	7	fluorescent resonance energy transfe	Ivanov AA (2017)	1
SOX4	5	NSD3	6	fluorescent resonance energy transfe	Ivanov AA (2017)	1
HIST1H3A	3	KDM1B	4	bioid	Lambert JP (2015)	1
TEAD2	2	AKT1	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
H2AFY	1	HIST1H4A	0	affinity chromatography technology	Sarma K (2014)	1
CBX5	3	HIST1H3A	3	affinity chromatography technology, pull down, pull down, unspecified method, imaging technique, bioid, affinity chromatography technology	Terada Y (2006), Lavigne M (2009), Lavigne M (2009), Dawson MA (2009), Dawson MA (2009), Lambert JP (2015), Huttlin EL (2017)	7
MYC	2	AKT1	1	fluorescent resonance energy transfe	Ivanov AA (2017)	1
H2AFY	1	HIST1H1A	0	affinity chromatography technology	Sarma K (2014)	1
CBX5	3	SMARCA2	17	affinity chromatography technology, pull down, affinity chromatography technology	Lavigne M (2009), Lavigne M (2009), Nozawa RS (2010)	3
ATM	9	CHEK2	2	enzymatic study, pull down, enzymatic study, enzymatic study, enzymatic study, enzymatic study	Lee JH (2004), Lee JH (2004), Matsuoka S (2000), Lee JH (2005), Zhou BB (2000), Chan DW (2000)	6
MNDA	0	NSD3	6	affinity chromatography technology, two hybrid	Weimann M (2013), Weimann M (2013)	2
CASP8	1	NSD3	6	two hybrid	Arroyo R (2015)	1
CBLC	1	MYC	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
TGFB1	2	DAXX	5	imaging technique	Chen TC (2014)	1
SMARCA2	17	ESR1	0	two hybrid	Ichinose H (1997)	1
H3F3C	0	NSD3	6	two hybrid	Weimann M (2013)	1
TEAD2	2	FGFR4	6	fluorescent resonance energy transfe	Ivanov AA (2017)	1
RAD51	3	ATM	9	affinity chromatography technology, affinity chromatography technology	Chen G (1999), Chen G (1999)	2
CDKN2A	1	NSD3	6	two hybrid	Arroyo R (2015)	1
BCL7C	0	SMARCC1	5	affinity chromatography technology, biochemical, affinity chromatography technology	Kaeser MD (2008), Wan C (2015), Huttlin EL (2017)	3
CHEK2	2	NSD3	6	two hybrid	Arroyo R (2015)	1
YEATS4	0	MYC	2	pull down, affinity chromatography technology, affinity chromatography technology	Piccinni E (2011), Huttlin EL (2015), Huttlin EL (2017)	3
SOX3	0	TEAD2	2	fluorescent resonance energy transfe	Ivanov AA (2017)	1
NSD3	6	SMARCC1	5	affinity chromatography technology	Rahman S (2011)	1
AKT1	1	NSD3	6	two hybrid	Arroyo R (2015)	1
CBX5	3	SMARCA4	19	affinity chromatography technology, pull down, two hybrid, affinity chromatography technology, affinity chromatography technology, pull down, pull down, affinity chromatography technology	Nielsen AL (2002), Nielsen AL (2002), Nielsen AL (2002), Lechner MS (2005), Lechner MS (2005), Lavigne M (2009), Lavigne M (2009), Nozawa RS (2010)	8
SMARCA4	19	ESR1	0	two hybrid, pull down	Ichinose H (1997), DiRenzo J (2000)	2
KDM1B	4	HIST3H3	0	enzymatic study	Yang Y (2015)	1
HIST3H3	0	BPTF	8	pull down, unspecified method	Varier RA (2010), Vermeulen M (2010)	2
ETV3	1	NSD3	6	two hybrid	Weimann M (2013)	1